Inhibition of Melanoma Growth by Adenoviral-Mediated HSV Thymidine Kinase Gene Transfer In Vivo
- 1 March 1995
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 104 (3) , 313-317
- https://doi.org/10.1111/1523-1747.ep12664614
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- The Basic Science of Gene TherapyScience, 1993
- Record Low Global Ozone in 1992Science, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Gene therapy for cancerThe Lancet, 1992
- Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.Journal of Clinical Oncology, 1992
- Trends in Survival From Malignant Melanoma: Remarkable Improvement in 23 YearsJNCI Journal of the National Cancer Institute, 1989
- Antiviral Activity and Mechanism of Action of GanciclovirClinical Infectious Diseases, 1988
- The rate of malignant melanoma in the United States: Are we making an impact?Journal of the American Academy of Dermatology, 1987